NHLBI Funds $22M to Five Institutions for Metabolomic Research into Cardiovascular, Lung Diseases
July 16, 2012
NHLBI Funds $22M to Five Institutions for Metabolomic Research into Cardiovascular, Lung Diseases
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Proteomics to Play Important Role in Ten-Year U Penn-Led Study to Predict NSAID Risk and Response
August 10, 2012 / ProteoMonitor - NCI Proteomics Office Inks MOUs with FDA, NHLBI
July 16, 2012 / GenomeWeb Daily News - 26,000-Patient Study Suggests Triple-Biomarker Approach Could Improve CKD Diagnosis
April 29, 2011 / ProteoMonitor - FHS Researchers Develop Multi-Biomarker Panel to Predict Risk of Chronic Kidney Disease
October 22, 2010 / ProteoMonitor - UT Health Science Center San Antonio Gets $11.6M for Cardiac Proteomics Study
September 7, 2010 / GenomeWeb Daily News